Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab.
Journal: Leukemia & lymphoma
Published: June 28, 2018
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 18, 2017
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
Journal: Science translational medicine
Published: May 18, 2016
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.
Journal: Acta haematologica
Published: July 02, 2014
Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation.
Journal: American journal of hematology
Published: June 05, 2014
MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
Journal: Cancer research
Published: July 23, 2013
Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 21, 2013
Lenalidomide enhances anti-myeloma cellular immunity.
Journal: Cancer immunology, immunotherapy : CII
Published: February 13, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026